Daesung Microbiological Labs. Co. Ltd
Researches and manufactures veterinary vaccines and medicines for livestock, fish, and canines.
036480 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 덕영대로 103, 의왕시
- Website:
- https://eng.dsmbio.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Daesung Microbiological Labs. Co., Ltd. is a veterinary pharmaceutical company engaged in the research, manufacture, and sale of animal medicines. Established in 1968, the company has over half a century of experience contributing to the health of the livestock industry. Its product portfolio includes a wide range of vaccines, antibiotics, and other therapeutic drugs for various animals, including swine, poultry, cattle, canines, and fish. As a leading vaccine manufacturer with KGMP (Korean Good Manufacturing Practice) certification, the company focuses on producing high-quality products aimed at disease prevention and promoting animal welfare.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Daesung Microbiological Labs. Co. Ltd and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Daesung Microbiological Labs. Co. Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Daesung Microbiological Labs. Co. Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
